mhurhangee/ep-ind-claims huggingface dataset:
A soft magnetic alloy ribbon including an alloy represented by a composition formula of Fe a Si b B c Cu d M e, M being at least one type of element selected from a group consisting of Nb, Mo, V, Zr, Hf, and W, and the formula satisfying 82.5 ≤ a ≤ 86, 0.3 ≤ b ≤ 3, 12.5 ≤ c ≤ 15.0, 0.05 ≤ d ≤ 0.9, and 0 ≤ e < 0.4 in at%, wherein a part of Fe content is optionally replaced with at least one type of element selected from Co and Ni up to 6 at% at a maximum, wherein 1 mass% or less of C (carbon) is optionally included, wherein 0.5 mass% or less of impurities is optionally included, wherein the soft magnetic alloy ribbon comprises a structure that has a crystal grain with a grain diameter of 60 nm or less in an amorphous phase, wherein a proportion of the crystal grain with a grain diameter of 60 nm or less is 50% or more in volume fraction, determined with a method defined in the description, wherein a saturation magnetic flux density of the soft magnetic alloy ribbon is 1.75 T or more, wherein an iron loss of the soft magnetic alloy ribbon at 1 kHz and at 1 T is 25 W/kg or less, wherein a density of the soft magnetic alloy is 7.45 g/cm 3 or more, wherein a ratio (L/W) of a magnetic flux density L to a magnetic flux density W is from 0.7 to 1.3, wherein the magnetic flux density L is a magnetic flux density when a magnetic field of 80 A/m is imposed in a casting direction of the soft magnetic alloy ribbon, and wherein the magnetic flux density W is a magnetic flux density when a magnetic field of 80 A/m is imposed in a direction orthogonal to the casting direction of the soft magnetic alloy ribbon. wherein a part of Fe content is optionally replaced with at least one type of element selected from Co and Ni up to 6 at% at a maximum, wherein 1 mass% or less of C (carbon) is optionally included, wherein 0.5 mass% or less of impurities is optionally included, wherein the soft magnetic alloy ribbon comprises a structure that has a crystal grain with a grain diameter of 60 nm or less in an amorphous phase, wherein a proportion of the crystal grain with a grain diameter of 60 nm or less is 50% or more in volume fraction, determined with a method defined in the description, wherein a saturation magnetic flux density of the soft magnetic alloy ribbon is 1.75 T or more, wherein an iron loss of the soft magnetic alloy ribbon at 1 kHz and at 1 T is 25 W/kg or less, wherein a density of the soft magnetic alloy is 7.45 g/cm 3 or more, wherein a ratio (L/W) of a magnetic flux density L to a magnetic flux density W is from 0.7 to 1.3, wherein the magnetic flux density L is a magnetic flux density when a magnetic field of 80 A/m is imposed in a casting direction of the soft magnetic alloy ribbon, and wherein the magnetic flux density W is a magnetic flux density when a magnetic field of 80 A/m is imposed in a direction orthogonal to the casting direction of the soft magnetic alloy ribbon.
A construction kit for a for a collapsible frame structure, characterized in that the construction kit comprises flat components of a type A (15, 25, 35) and components of at least one type B (20, 30, 40, 45), which are each formed in the shape of rectangles, each of which has two long sides and two edge sides, wherein the components of type A (15, 25, 35) and of type B (20, 30, 40, 45) each have a thickness and each have an identical length and an identical width, the components of type A (15, 25, 35) and of type B (20, 30, 40, 45) are each subdivided into n equally large sections of length L/n, which are bounded by n+1 sectional boundaries, wherein the edge sides of the components of types A and B (20, 30, 40, 45) form the respective outer sectional boundaries, and the central vertical line between the long sides of the respective components forms the central sectional boundary, wherein the central vertical line is an axis of symmetry, and characterized in that, in the components of type A, on a long side of the respective component, n-2 slots are arranged along a partial length of the respective sectional boundaries and are located between the edge sides and the axis of symmetry, and wherein, in the components of type B (20, 30, 40, 45), n-4 slots are arranged along selected sectional boundaries, which are located between the edge sides and the axis of symmetry, wherein, starting from a long side, a portion of the n-4 slots are arranged along a partial length of the respective sectional boundaries, and, starting from the other long side, the other portion of the n-4 slots are arranged on the respective other sectional boundaries, and wherein, starting from a long side, at least 2 of the n-4 slots of the components of type B (20, 30, 40, 45) are each arranged along the sectional boundaries, which are directly adjacent to the axis of symmetry, and, furthermore, starting from the other long side of the component, at least 2 of the n-4 slots of the component of type B (20, 30, 40, 45) are arranged along the sectional boundaries, which are adjacent to the respective edge sides, and n is 8, 10, or 12.
A multilayer structure comprising a barrier layer made of at least one selected from ethylene-vinyl alcohol copolymer or modified ethylene-vinyl alcohol copolymer with 50 % or less elongation at break conforming to JIS K 7113 at 20 °C and 65 %RH and an elastomer layer made of polyurethane-based thermoplastic elastomer with 100 % or more elongation at break conforming to JIS K 7113 at 20 °C and 65 %RH, wherein a difference between an input deformation amount of the multilayer structure at the time of 100 % deformation input and a plastic deformation amount of the multilayer structure at the time of 100 % deformation input is larger than a deformation amount at a tolerance point, wherein a thickness of each barrier layer is 10 μm or less and a thickness of the whole multilayer structure is 1-500 μm.
A pneumatic tire comprising two annular bead portions each having a bead core, a carcass extending between the bead portions through sidewall portions and a tread portion, wherein the carcass includes at least two axially inner plies (1, 2) which extend down from the tread and axially inward of the bead core, said at least two axially inner plies being wound around the bead core forming respective turn-ups (1A, 2A), each turn-up (1A, 2A) being located axially outward of the bead core, characterized in that the carcass further includes at least one axially outer ply (5, 6) which extends down from the tread towards the bead core and which is positioned axially outward of the bead core, wherein the at least one axially outer ply (5, 6) is formed using reinforcements having (i) a higher break strength than the reinforcements of the at least two axially inner plies (1, 2) and/or (ii) a lower % elongation at break than the reinforcements of the at least two axially inner plies ply (1, 2).
A method for growing group III nitride crystals using a cylindrical high-pressure vessel having (i) a body defining at least a crystallization region and a nutrient region separated by one or more flow restricting baffles, (ii) a lid, and (iii) a clamp formed of precipitation hardenable Ni-Cr based superalloy having a grain flow in a radial direction in the clamp, comprising the following steps: (a) loading group III-nitride seed crystals in the crystallization region and group III-containing source in the nutrient region; (b) loading an alkali metal-containing mineralizer into the high-pressure vessel in a manner that the mineralizer has minimal exposure to oxygen or moisture; (c) sealing the high-pressure vessel; (d) pumping the high-pressure vessel to a pressure less than 1 x 10 -5 mbar; (e) filling the high-pressure vessel with ammonia; (f) ramping the temperature of the crystallization region above 500°C; (g) maintaining the temperature condition described in (f) for long enough to grow crystals; (h) releasing ammonia to stop crystal growth; and (i) unsealing the high-pressure vessel. (a) loading group III-nitride seed crystals in the crystallization region and group III-containing source in the nutrient region; (b) loading an alkali metal-containing mineralizer into the high-pressure vessel in a manner that the mineralizer has minimal exposure to oxygen or moisture; (c) sealing the high-pressure vessel; (d) pumping the high-pressure vessel to a pressure less than 1 x 10 -5 mbar; (e) filling the high-pressure vessel with ammonia; (f) ramping the temperature of the crystallization region above 500°C; (g) maintaining the temperature condition described in (f) for long enough to grow crystals; (h) releasing ammonia to stop crystal growth; and (i) unsealing the high-pressure vessel.
A prosthetic heart valve device comprising: an anchoring member having an annular fixation frame with an upstream portion and a downstream portion; a tubular valve support having a first portion coupled to the downstream portion of the fixation frame and a second portion spaced radially inward from the upstream portion of the fixation frame; a valve assembly coupled to the valve support and having at least one leaflet movable from a closed position in which blood flow is blocked through the valve support and an open position in which blood flow is allowed through the valve support in a downstream direction; and an extension member coupled to the fixation frame and extending radially outward therefrom, wherein the extension member includes a plurality of wires, characterized in that at least a portion of the wires include an inner core surrounded by an outer material, and wherein (a) the inner core is a first material, (b) the outer material is a second material different than the first material and has a thickness, (c) the wires include a plurality of recesses extending through at least a portion of the thickness of the outer material, and (d) a therapeutic agent in the recesses for delivery to the anatomy when the prosthetic heart valve device is positioned at a native annulus, or (d) a radiopaque material in the recesses. an anchoring member having an annular fixation frame with an upstream portion and a downstream portion; a tubular valve support having a first portion coupled to the downstream portion of the fixation frame and a second portion spaced radially inward from the upstream portion of the fixation frame; a valve assembly coupled to the valve support and having at least one leaflet movable from a closed position in which blood flow is blocked through the valve support and an open position in which blood flow is allowed through the valve support in a downstream direction; and an extension member coupled to the fixation frame and extending radially outward therefrom, wherein the extension member includes a plurality of wires, characterized in that at least a portion of the wires include an inner core surrounded by an outer material, and wherein (a) the inner core is a first material, (b) the outer material is a second material different than the first material and has a thickness, (c) the wires include a plurality of recesses extending through at least a portion of the thickness of the outer material, and (d) a therapeutic agent in the recesses for delivery to the anatomy when the prosthetic heart valve device is positioned at a native annulus, or (d) a radiopaque material in the recesses.
Device for braking a rotation movement of a rotation element, preferably a wheel, particularly preferably a wheel on a rollator, walker, pram, wheelchair, baby walker, running bike or play equipment, comprising a carrier element for supporting against an axis of a rotation element or a carrier frame supporting the rotation element, a support element rotatable about an axis of rotation relative to the carrier element for force-transmitting connection to the rotation element, characterised in that the device comprises a damping element extending between the carrier element and the support element, wherein the damping element is arranged to provide a damping force opposing a change in length of the damping element, the height of which is dependent on the speed of the change in length, wherein a first side of the damping element is mounted in such a way on the carrier element and a second side of the damping element, which is longitudinally displaceable relative to the first side, is mounted on the support element in such a way that a rotation of the support element around the axis of rotation causes a change in length of the damping element at least in a predetermined angle section in the circumferential direction with respect to the axis of rotation, and a damping force generated in the damping element causes a braking of the rotation of the support element. a carrier element for supporting against an axis of a rotation element or a carrier frame supporting the rotation element, a support element rotatable about an axis of rotation relative to the carrier element for force-transmitting connection to the rotation element, characterised in that the device comprises a damping element extending between the carrier element and the support element, wherein the damping element is arranged to provide a damping force opposing a change in length of the damping element, the height of which is dependent on the speed of the change in length, wherein a first side of the damping element is mounted in such a way on the carrier element and a second side of the damping element, which is longitudinally displaceable relative to the first side, is mounted on the support element in such a way that a rotation of the support element around the axis of rotation causes a change in length of the damping element at least in a predetermined angle section in the circumferential direction with respect to the axis of rotation, and a damping force generated in the damping element causes a braking of the rotation of the support element.
A refrigerator comprising: a storage container having an inner accommodating space to store stuff therein; and an air pressure adjusting apparatus to allow external air to be introduced into the storage container based on internal air pressure of the storage container, so as to increase the internal air pressure; characterized by the air pressure adjusting apparatus comprising: a casing having a through hole formed through the casing to allow for an introduction of external air therethrough; a movable member installed in the casing to be movable toward and away from the through hole so as to selectively open and close the through hole based on a difference between the internal air pressure of the storage container and the external air pressure; a supporting member fixedly installed within the casing and being spaced apart from the movable member; and an elastic member fixedly installed between the movable member and the supporting member. a storage container having an inner accommodating space to store stuff therein; and an air pressure adjusting apparatus to allow external air to be introduced into the storage container based on internal air pressure of the storage container, so as to increase the internal air pressure; characterized by the air pressure adjusting apparatus comprising: a casing having a through hole formed through the casing to allow for an introduction of external air therethrough; a movable member installed in the casing to be movable toward and away from the through hole so as to selectively open and close the through hole based on a difference between the internal air pressure of the storage container and the external air pressure; a supporting member fixedly installed within the casing and being spaced apart from the movable member; and an elastic member fixedly installed between the movable member and the supporting member. a casing having a through hole formed through the casing to allow for an introduction of external air therethrough; a movable member installed in the casing to be movable toward and away from the through hole so as to selectively open and close the through hole based on a difference between the internal air pressure of the storage container and the external air pressure; a supporting member fixedly installed within the casing and being spaced apart from the movable member; and an elastic member fixedly installed between the movable member and the supporting member.
A light-emitting device comprising: a body comprising a first semiconductor layer, an active layer, and a second semiconductor layer; a first electrode and a second electrode provided on a first surface of the body, the first electrode and the second electrode being in contact with the first semiconductor layer and the second semiconductor layer, respectively; a third electrode and a fourth electrode provided on a second surface of the body, the third electrode and the fourth electrode being in contact with the first semiconductor layer and the second semiconductor layer, respectively; a first trench passing through the first semiconductor layer and the active layer and exposing the second semiconductor layer; and wherein the second electrode is in contact with the second semiconductor layer via the first trench, and characterised in that the second electrode and the fourth electrode are not connected to each other. a body comprising a first semiconductor layer, an active layer, and a second semiconductor layer; a first electrode and a second electrode provided on a first surface of the body, the first electrode and the second electrode being in contact with the first semiconductor layer and the second semiconductor layer, respectively; a third electrode and a fourth electrode provided on a second surface of the body, the third electrode and the fourth electrode being in contact with the first semiconductor layer and the second semiconductor layer, respectively; a first trench passing through the first semiconductor layer and the active layer and exposing the second semiconductor layer; and wherein the second electrode is in contact with the second semiconductor layer via the first trench, and characterised in that the second electrode and the fourth electrode are not connected to each other.
A composition for use in treating a patient having a cancer or a genetic disorder treatable using hematopoietic stem cells, the composition comprising: hematopoietic stem cells (HSCs), and an effective amount of one or a plurality of chemical compounds of formula: R 1 - M 1 -N(R 2)-M 2 - M 3 - M 4 - M 5 - M 6 - R 3 where: R 1 is aryl, R 2 is aralkyl, M 1 is CH 2, M 2 is CO, M 3 is absent or O, M 4 is absent, M 5 is absent, M 6 is (CH 2) q or (CH 2 CH 2 O) q, wherein q is an integer from 1 to 6, and R 3 is CON R 13 R 14, where R 13 and R 14 are independently aralkyl, wherein the one or plurality of chemical compounds are capable of enhancing integrin-mediated binding of cells to their respective ligands, and where the effective amount is between about 1 fM and about 300 μM. hematopoietic stem cells (HSCs), and an effective amount of one or a plurality of chemical compounds of formula: R 1 - M 1 -N(R 2)-M 2 - M 3 - M 4 - M 5 - M 6 - R 3 where: R 1 is aryl, R 2 is aralkyl, M 1 is CH 2, M 2 is CO, M 3 is absent or O, M 4 is absent, M 5 is absent, M 6 is (CH 2) q or (CH 2 CH 2 O) q, wherein q is an integer from 1 to 6, and R 3 is CON R 13 R 14, where R 13 and R 14 are independently aralkyl, R 1 is aryl, R 2 is aralkyl, M 1 is CH 2, M 2 is CO, M 3 is absent or O, M 4 is absent, M 5 is absent, M 6 is (CH 2) q or (CH 2 CH 2 O) q, wherein q is an integer from 1 to 6, and R 3 is CON R 13 R 14, where R 13 and R 14 are independently aralkyl, wherein the one or plurality of chemical compounds are capable of enhancing integrin-mediated binding of cells to their respective ligands, and where the effective amount is between about 1 fM and about 300 μM.
A calcium fortified baked product comprising: flour that is substantially free of bran and free of wheat middlings; from 0.1% to 2.2% by weight elemental calcium (i.e. calcium in any oxidation state, including Ca 2+) based on the weight of said baked product, said calcium carbonate having a mean particle diameter from 0.05 μm to 30 μm; a soluble organic acid; and wherein the baked product has a pH from 3.0 to 6.5, and has a taste, texture, and crumb structure that is substantially identical to the same quality of an otherwise identical baked product that has not been fortified with calcium, characterized in that the organic acid is in a weight ratio to said calcium carbonate of 1:4 to 1:20, but subject to the proviso that weight ratios of 1:4 to 1:7 are excluded. flour that is substantially free of bran and free of wheat middlings; from 0.1% to 2.2% by weight elemental calcium (i.e. calcium in any oxidation state, including Ca 2+) based on the weight of said baked product, said calcium carbonate having a mean particle diameter from 0.05 μm to 30 μm; a soluble organic acid; and wherein the baked product has a pH from 3.0 to 6.5, and has a taste, texture, and crumb structure that is substantially identical to the same quality of an otherwise identical baked product that has not been fortified with calcium, characterized in that the organic acid is in a weight ratio to said calcium carbonate of 1:4 to 1:20, but subject to the proviso that weight ratios of 1:4 to 1:7 are excluded.
A nutrition supplement for use in the treatment of cancer in a subject, wherein the treatment comprises (i) administering the nutrition supplement, wherein the nutrition supplement comprises soybean oil, phospholipids, and glycerol; and (ii) administering a nanotherapeutic agent to the subject, wherein the nanotherapeutic agent comprises a therapeutic agent and a nanocarrier, wherein the nanotherapeutic agent comprises a platinum-containing chemotherapeutic agent, wherein the chemotherapeutic agent is the platinum-containing chemotherapeutic agent dichloro(1,2-diaminocyclohexane)platinum (DACHPt), wherein the nanocarrier is selected from the group consisting of a liposome, a lipid-coated nanoparticle, a protein-coated nanoparticle, and a polymer-coated nanoparticle, wherein said nutrition supplement is administered to the subject about 0.1 hours to about 24 hours before the nanotherapeutic agent is administered to the subject. (i) administering the nutrition supplement, wherein the nutrition supplement comprises soybean oil, phospholipids, and glycerol; and (ii) administering a nanotherapeutic agent to the subject, wherein the nanotherapeutic agent comprises a therapeutic agent and a nanocarrier, wherein the nanotherapeutic agent comprises a platinum-containing chemotherapeutic agent, wherein the chemotherapeutic agent is the platinum-containing chemotherapeutic agent dichloro(1,2-diaminocyclohexane)platinum (DACHPt), wherein the nanocarrier is selected from the group consisting of a liposome, a lipid-coated nanoparticle, a protein-coated nanoparticle, and a polymer-coated nanoparticle, wherein said nutrition supplement is administered to the subject about 0.1 hours to about 24 hours before the nanotherapeutic agent is administered to the subject.
A mixing apparatus for mixing slaughter offal with a preservative agent in a controlled manner, the apparatus comprising an offal collection tank with a bottom provided with a discharge opening connectable to a closable discharge, an agitator extending into the offal collection tank, and a pump unit operatively connectable to the discharge, wherein the apparatus further comprises a preservative reservoir mounted on top of the collection tank and wherein the collection tank comprises a sensor for determining whether a mucosa compound reaches a certain maximum level and a programmable control unit for stopping the supply of mucosa compound into the collection tank after the sensor detects that the maximum level is reached.